Page last updated: 2024-11-07

lophotoxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lophotoxin: belongs to the cembrene class of diterpenoids; neuromuscular toxin isolated from several pacific gorgonians of the genus Lophogorgia; RN given refers to (1R-(1R*,2S*,4S*,10R*,12R*,14R*,15R*))-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID108179
MeSH IDM0095953

Synonyms (12)

Synonym
lophotoxin
78697-56-0
11,16,18,19-tetraoxapentacyclo(12.2.2.1(sup 6,9).0(sup 1,15).0(10,12))nonadeca-6,8-diene-7-carboxaldehyde, 2-(acetyloxy)-12-methyl-4-(1-methylethenyl)-17-oxo-, (1r-(1r*,2s*,4s*,10r*,12r*,14r*,15r*))-
11,16,18,19-tetraoxapentacyclo(12.2.2.16,9.01,15.010,12)nonadeca-6,8-diene-7-carboxaldehyde, 2-(acetyloxy)-12-methyl-4-(1-methylethenyl)-17-oxo-, (1r-(1r*,2s*,4s*,10r*,12r*,14r*,15r*))-
brn 4339458
11,16,18,19-tetraoxapentacyclo(12.2.2.16,9.01,15.010,12)nonadeca-6,8-diene-7-carboxaldehyde, 2-(acetyloxy)-12-methyl-4-(1-methylethenyl)-17-oxo-, (1r,2s,4s,10r,12r,14r,15r)-
6ll2iet058 ,
unii-6ll2iet058
lophotoxin [mi]
(22r,23r,41r,44r,45r,5s,7s)-14-formyl-23-methyl-42-oxo-7-(prop-1-en-2-yl)-43,46-dioxa-1(2,5)-furana-2(2,3)-oxirana-4(4,1)-bicyclo[3.1.0]hexanacyclooctaphane-5-yl acetate
[(1r,2s,4s,10r,12r,14r,15r)-7-formyl-12-methyl-17-oxo-4-prop-1-en-2-yl-11,16,18,19-tetraoxapentacyclo[12.2.2.16,9.01,15.010,12]nonadeca-6,8-dien-2-yl] acetate
AKOS040752671

Research Excerpts

Overview

Lophotoxin is a diterpene lactone isolated from gorgonian corals. It inhibits agonist binding to nicotinic acetylcholine receptors by reacting covalently with Tyr190.

ExcerptReferenceRelevance
"Lophotoxin is a small cyclic diterpene that irreversibly inhibits agonist binding to nicotinic acetylcholine receptors by reacting covalently with Tyr190 in the alpha-subunits of the receptor. "( Structure/activity and molecular modeling studies of the lophotoxin family of irreversible nicotinic receptor antagonists.
Abramson, SN; Fenical, W; Harold, EE; Tapiolas, DM; Taylor, P; Trischman, JA, 1991
)
1.97
"Lophotoxin is a diterpene lactone isolated from gorgonian corals. "( Lophotoxin: selective blockade of nicotinic transmission in autonomic ganglia by a coral neurotoxin.
Chiappinelli, VA; Culver, P; Sorenson, EM, 1987
)
3.16

Effects

ExcerptReferenceRelevance
"Lophotoxin has also been shown to block nicotinic transmission in autonomic ganglia of the frog and in ileal strips of guinea pig and rabbit."( Lophotoxin: selective blockade of nicotinic transmission in autonomic ganglia by a coral neurotoxin.
Chiappinelli, VA; Culver, P; Sorenson, EM, 1987
)
2.44

Dosage Studied

ExcerptRelevanceReference
" ACh dose-response curves suggested that his inhibition was noncompetitive."( Diterpenoids from Caribbean gorgonians act as noncompetitive inhibitors of the nicotinic acetylcholine receptor.
Eterović, VA; Ferchmin, PA; Hann, RM; Lee, YH; Li, L; McNamee, MG; Rodriguez, AD, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (47.83)18.7374
1990's10 (43.48)18.2507
2000's2 (8.70)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.57 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (13.04%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (86.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]